APA (7th ed.) Citation

Altmann, A., Eisenhut, M., Bauder-Wüst, U., Markert, A., Askoxylakis, V., Hess-Stumpp, H., & Haberkorn, U. (2010). Therapy of thyroid carcinoma with the histone deacetylase inhibitor MS-275. European journal of nuclear medicine and molecular imaging, 37(12), . https://doi.org/10.1007/s00259-010-1573-3

Chicago Style (17th ed.) Citation

Altmann, Annette, Michael Eisenhut, Ulrike Bauder-Wüst, Annette Markert, Vasileios Askoxylakis, Holger Hess-Stumpp, and Uwe Haberkorn. "Therapy of Thyroid Carcinoma with the Histone Deacetylase Inhibitor MS-275." European Journal of Nuclear Medicine and Molecular Imaging 37, no. 12 (2010). https://doi.org/10.1007/s00259-010-1573-3.

MLA (9th ed.) Citation

Altmann, Annette, et al. "Therapy of Thyroid Carcinoma with the Histone Deacetylase Inhibitor MS-275." European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 12, 2010, https://doi.org/10.1007/s00259-010-1573-3.